- The Wall Street Journal•13 hours ago
GlaxoSmithKline is expected to post revenue of GBP7.25 billion for the first quarter, up 16% from the year-earlier period, when it reports results Wednesday.
- Market Realist•17 hours ago
GlaxoSmithKline’s (GSK) Pharmaceuticals segment revenues have declined substantially in 2015 due to the divestment of its Oncology business to Novartis (NVS) in March 2015.
- Market Realist•18 hours ago
Analysts expect ~16.5% growth in GlaxoSmithKline’s (GSK) 1Q17 revenues to ~7.3 billion pounds following strong product launches, acquired products from Novartis (NVS), and improvement in the supply chain....
GSK : Summary for GlaxoSmithKline PLC Common Stoc - Yahoo Finance
GlaxoSmithKline plc (GSK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||41.30 - 41.74|
|52 Week Range||37.20 - 45.58|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||89.40|
|Dividend & Yield||2.00 (4.79%)|
|1y Target Est||N/A|